Early and long-term effects of dupilumab treatment on circulating T-cell functions in moderate-to-severe atopic dermatitis patients. J Invest Dermatol 2021 Feb 18
Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas. J Clin Oncol 2021 Feb 18:JCO2002446
European Task Force on Atopic Dermatitis (ETFAD): position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics. J Eur Acad Dermatol Venereol 2021 Feb 15
Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study. J Dermatolog Treat 2021 Feb 08:1-9
Identification and Purification of Novel Low-Molecular-Weight Lupine Allergens as Components for Personalized Diagnostics. Nutrients 2021 Jan 28; 13(2)
Accidental food-allergic reactions are associated with higher costs and more sick leave but not with quality of life. Clin Exp Allergy 2021 Feb 01
Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies. Acta Derm Venereol 2021 Feb 17; 101(2):adv00402
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma. Am J Clin Dermatol 2021 Jan; 22(1):101-115
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study. J Dermatolog Treat 2021 Mar; 32(2):164-173
Allergen labelling: Current practice and improvement from a communication perspective. Clin Exp Allergy 2021 Jan 13
Subtyping Cutaneous Melanoma Matters. JNCI Cancer Spectr 2020 Dec; 4(6):pkaa097
Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma. JAMA Dermatol 2021 Feb 01; 157(2):166-173
Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients. Pediatr Allergy Immunol 2020 Dec 11
EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers. Allergy 2020 12; 75(12):3287-3289
IgE-binding to vicilin-like antimicrobial peptides is associated with systemic reactions to macadamia nut. Clin Transl Allergy 2020 Dec 02; 10(1):55